PRAX
NASDAQ:PRAX
Praxis Precision Medicines
- Stock
Last Close
57.54
26/07 20:00
Market Cap
819.81M
Beta: 3.01
Volume Today
145.59K
Avg: 1.66M
PE Ratio
−41.39
PFCF: −3.16
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 3.03M - | 3.38M 11.51% | 7.43M 120.10% | 12.73M 71.19% | 10.24M 19.51% | ||
average receivables | |||||||
book value per share | 1.11 - | 2.34 111.08% | 7.51 221.66% | 5.91 21.35% | 1.65 72.05% | 0.01 99.36% | |
capex per share | -0.00 - | -0.01 26.31% | 0.00 101.74% | -0.02 23,762.03% | -0.01 61.06% | -0.00 99.92% | |
capex to depreciation | -63 - | -2.78 95.58% | 0.08 102.87% | -5.77 7,311.54% | -1.06 81.63% | -0.10 90.15% | |
capex to operating cash flow | 0.00 - | 0.00 1.37% | -0.00 102.47% | 0.01 11,190.40% | 0.00 71.54% | 0.00 81.25% | |
capex to revenue | -0.02 - | ||||||
cash per share | 1.35 - | 2.61 92.89% | 7.75 197.08% | 6.50 16.15% | 2.18 66.46% | 0.01 99.43% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 0.03 - | 0.00 91.77% | 0.03 1,070.27% | 0.04 32.86% | 0.03 27.50% | ||
debt to equity | 0.04 - | 0.00 92.70% | 0.03 1,195.11% | 0.06 72.19% | 0.04 39.50% | ||
dividend yield | |||||||
earnings yield | -0.07 - | -0.07 3.39% | -0.03 60.52% | -0.20 579.59% | -1.94 873.34% | -0.00 99.96% | |
enterprise value | 350.98M - | 434.17M 23.70% | 1.81B 316.81% | 701.95M 61.21% | 52.60M 92.51% | 146.84B 279,067.11% | |
enterprise value over ebitda | -13.36 - | -12.21 8.60% | -29.20 139.18% | -4.19 85.64% | -0.24 94.17% | -1.16K 474,819.65% | |
ev to operating cash flow | -16.94 - | -12.99 23.30% | -34.39 164.71% | -5.64 83.61% | -0.28 94.96% | -1.32K 464,717.16% | |
ev to sales | 60.01K - | ||||||
free cash flow per share | -1.57 - | -1.95 24.61% | -1.37 29.54% | -2.96 115.17% | -4.02 36.01% | -0.02 99.58% | |
free cash flow yield | -0.06 - | -0.07 24.61% | -0.02 64.40% | -0.15 500.95% | -1.69 1,025.77% | -0.00 99.96% | |
graham net net | 0.96 - | 2.17 124.68% | 7.34 238.61% | 5.51 24.91% | 1.33 75.81% | 0.01 99.28% | |
graham number | 7.06 - | 10.42 47.73% | 16.52 58.54% | 22.86 38.34% | 13.10 42.67% | 0.07 99.49% | |
income quality | 0.78 - | 0.94 20.51% | 0.85 9.55% | 0.75 12.41% | 0.86 15.96% | 0.90 4.27% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -178.89 - | 513.09 - | |||||
interest debt per share | 0.01 - | 0.08 787.55% | 0.02 76.53% | 0.20 918.61% | 0.09 56.35% | 0.00 99.57% | |
inventory turnover | |||||||
invested capital | 0.04 - | 0.00 92.70% | 0.03 1,195.11% | 0.06 72.19% | 0.04 39.50% | ||
market cap | 368.93M - | 477.53M 29.44% | 2.11B 340.92% | 836.34M 60.28% | 109.71M 86.88% | 146.92B 133,817.64% | |
net current asset value | 13.98M - | 37.91M 171.23% | 286.61M 655.92% | 245.47M 14.35% | 71.82M 70.74% | 66.60M 7.26% | |
net debt to ebitda | 0.68 - | 1.22 78.47% | 4.77 291.56% | 0.80 83.18% | 0.27 66.92% | 0.62 134.75% | |
net income per share | -2.00 - | -2.07 3.39% | -1.62 21.86% | -3.93 143.33% | -4.62 17.59% | -0.02 99.60% | |
operating cash flow per share | -1.56 - | -1.95 24.61% | -1.38 29.32% | -2.93 113.36% | -4.01 36.82% | -0.02 99.58% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | 35.46 - | ||||||
return on tangible assets | -1.34 - | -0.74 44.36% | -0.20 72.61% | -0.57 179.56% | -1.85 224.67% | -1.40 24.26% | |
revenue per share | 0.00 - | ||||||
roe | -1.81 - | -0.89 51.02% | -0.22 75.71% | -0.67 209.38% | -2.80 320.78% | -1.77 36.80% | |
roic | -1.56 - | -0.83 46.65% | -0.21 74.16% | -0.63 195.59% | -2.54 301.50% | -1.69 33.48% | |
sales general and administrative to revenue | 17.19 - | ||||||
shareholders equity per share | 1.11 - | 2.34 111.08% | 7.51 221.66% | 5.91 21.35% | 1.65 72.05% | 0.01 99.36% | |
stock based compensation to revenue | 10.16 - | ||||||
tangible asset value | 14.68M - | 40.11M 173.21% | 287.46M 616.62% | 250.81M 12.75% | 76.11M 69.66% | 69.67M 8.46% | |
tangible book value per share | 1.11 - | 2.34 111.08% | 7.51 221.66% | 5.91 21.35% | 1.65 72.05% | 0.01 99.36% | |
working capital | 13.98M - | 38.68M 176.65% | 286.61M 641.01% | 249.78M 12.85% | 75.32M 69.85% | 69.13M 8.21% |
All numbers in USD (except ratios and percentages)